Detalhe da pesquisa
1.
Exercise Tolerance in Patients Treated With a Durable Left Ventricular Assist Device: Importance of Myocardial Recovery.
J Card Fail
; 27(4): 486-493, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33347995
2.
Prasugrel or double-dose clopidogrel to overcome clopidogrel low-response--the TAILOR (Thrombocytes And IndividuaLization of ORal antiplatelet therapy in percutaneous coronary intervention) randomized trial.
Platelets
; 25(7): 506-12, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24245960
3.
Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiology.
Cardiovasc Drugs Ther
; 27(3): 239-45, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23380983
4.
A single center, open, randomized study investigating the clinical safety and the endothelial modulating effects of a prostacyclin analog in combination with eptifibatide in patients having undergone primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction.
Prostaglandins Other Lipid Mediat
; 99(3-4): 87-95, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22951358
5.
Hypercoagulation assessed by thromboelastography is neither related to infarct size nor to clinical outcome after primary percutaneous coronary intervention.
Clin Appl Thromb Hemost
; 20(8): 825-31, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23613040